Abstract 9‐Arylacridine‐1,8‐dione derivatives were prepared in an ionic liquid medium in the presence of CeCl 3 ċ 7H 2 O through an one‐pot procedure. The method presented here has the advantages of environmental benignancy, good‐to‐excellent yields, and simple operational procedure. Moreover, the solvent and catalyst can be easily recovered and reused for several runs without obvious loss of activity.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: